These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9808859

  • 1. A randomized, double-blind, placebo-controlled, crossover study to assess the immediate effect of sublingual glyceryl trinitrate on the ankle brachial pressure index, claudication, and maximum walking distance of patients with intermittent claudication.
    Walker SR, Tennant S, MacSweeney ST.
    J Vasc Surg; 1998 Nov; 28(5):895-900. PubMed ID: 9808859
    [Abstract] [Full Text] [Related]

  • 2. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R, Walker S, MacSweeney S.
    Curr Med Res Opin; 2001 Nov; 17(2):113-5. PubMed ID: 11759179
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up.
    Delis KT, Nicolaides AN, Wolfe JH, Stansby G.
    J Vasc Surg; 2000 Apr; 31(4):650-61. PubMed ID: 10753272
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication.
    Shahin Y, Barnes R, Barakat H, Chetter IC.
    Atherosclerosis; 2013 Dec; 231(2):283-90. PubMed ID: 24267241
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL, Cutler BS, Meissner MH, Strandness DE.
    Circulation; 1998 Aug 18; 98(7):678-86. PubMed ID: 9715861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial of treatment with intermittent negative pressure for intermittent claudication.
    Hoel H, Pettersen EM, Høiseth LØ, Mathiesen I, Seternes A, Hisdal J.
    J Vasc Surg; 2021 May 18; 73(5):1750-1758.e1. PubMed ID: 33899743
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG, Ware JE, McCarthy WJ, Zhang P, Forbes WP, Heckman J, Hiatt WR.
    J Am Geriatr Soc; 2002 Dec 18; 50(12):1939-46. PubMed ID: 12473004
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral Beraprost sodium, a prostaglandin I(2) analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Beraprost et Claudication Intermittente (BERCI) Research Group.
    Lièvre M, Morand S, Besse B, Fiessinger JN, Boissel JP.
    Circulation; 2000 Jul 25; 102(4):426-31. PubMed ID: 10908215
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intermittent claudication: exercise-increased walking distance is not related to improved cardiopulmonary fitness.
    Ng PW, Hollingsworth SJ, Luery H, Kumana TJ, Chaloner EJ.
    Eur J Vasc Endovasc Surg; 2005 Oct 25; 30(4):391-4. PubMed ID: 15963739
    [Abstract] [Full Text] [Related]

  • 20. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
    Mohler ER, Hiatt WR, Olin JW, Wade M, Jeffs R, Hirsch AT.
    J Am Coll Cardiol; 2003 May 21; 41(10):1679-86. PubMed ID: 12767646
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.